A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 3392
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IPSS
Long Form : International Prostate Symptom Score
No. Year Title Co-occurring Abbreviation
2021 'Top-Down' holmium laser enucleation of the prostate. Report of initial cases performed by a single surgeon. HoLEP, PVR, QoL, SUI, UUI
2021 A Modified Technique of Thulium Laser Enucleation for Benign Prostatic Hyperplasia With Non-morcellator Approach. PSA, PVR, QoL
2021 A Randomized Crossover Pilot Study Examining the Effect of Carvedilol and Terazosin plus Enalapril on Urinary Symptoms of Patients with Hypertension and Benign Prostatic Hyperplasia. BP, BPH, HTN, LUTS, PSA, PVR
2021 Add-on treatment with mirabegron may improve quality of life in patients with benign prostatic hyperplasia complaining of persistent storage symptoms after tamsulosin monotherapy. OABSS, PVR, QoL
2021 Age at surgery is not a prognostic factor for the AdVance-XP male sling efficacy: A post-hoc analysis of a prospective 7-year multicentric study. ICIQ-SF, IIEF-5, IQOL, PGI-I, PPI
2021 An Optimal Surgical Plane for Laparoscopic Functional Total Mesorectal Excision in Rectal Cancer. BMI, NVB, TME
2021 Analysis of radioactive implant migration in patients treated with iodine-125 seeds for permanent prostate brachytherapy with MRI-classified median lobe hyperplasia. DVH, MLH, PPB
2021 Analysis of Voiding Impairment after Prostate Biopsy and the Effect of Doxazosin Treatment: Outcomes from a Regional Cancer Center. TRUS
2021 Anesthetic Technique (Spinal vs. General Anesthesia) in Holmium Laser Enucleation of the Prostate: Retrospective Analysis of Procedural and Functional Outcomes among 1,159 Patients. ASA, GA, HoLEP, IQR, MVAs, SA
10  2021 Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia in medium-to-large-sized prostates (ATHLETE): protocol of a prospective randomised trial. BPH
11  2021 Association between intravesical prostatic protrusion and clinical outcomes in prostatic artery embolization. IPP, PAE, QoL
12  2021 Association of hypogonadism symptoms and serum hormones in aging males. AMS, BioT, FT, IIEF-5, LH, SHBG, TT
13  2021 Association of Lower Urinary Tract Symptoms Based on the International Prostate Symptom Score and Cardiovascular Disease. AF, CAD, CI, CVD, LUTS, PR
14  2021 Autoimmune manifestations associated with myelodysplastic syndrome predict a poor prognosis. AIMs, MDS
15  2021 Bounded Integer Modeling of Symptom Scales Specific to Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. BI, BII, CV, QoL
16  2021 Calcium Channel Blockers Are Associated with Nocturia in Men Aged 40 Years or Older. AHTs, CCBs, OR
17  2021 Can malleable penile prosthesis implantation improve voiding dysfunction in men with concurrent erectile dysfunction and buried penis? IIEF, PGI-I, SEP
18  2021 Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study. LUTS, OAB-q, QoL
19  2021 Clinical Efficacy of Multi-Focal Low-Intensity Extracorporeal Shockwave Therapy in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Prospective-Randomized, Double Blind, Placebo-Controlled Study. IIEF-5, MESWT, NIH-CPSI, VAS
20  2021 Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia-related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity. LUTSs
21  2021 Comparison of 532-nm GreenLight HPS laser with 980-nm diode laser vaporization of the prostate in treating patients with lower urinary tract symptom secondary to benign prostatic hyperplasia: a meta-analysis. BPH, DVP, LUTS, QoL
22  2021 Comparison of different en bloc holmium laser enucleation of the prostate techniques to reduce the rate of postoperative transient urinary incontinence. HoLEP, TUI
23  2021 Comparison of Efficacy of Different Surgical Techniques for Benign Prostatic Obstruction. BOOI, BPO, HoLEP, PVP, QoL, TURP
24  2021 Comparison of efficiency of vascular-preserving urethroplastic methods of the bulbo-membranous part of the urethra. ---
25  2021 Comparison of oncological and functional outcomes and quality of life after transanal or laparoscopic total mesorectal excision for rectal cancer: a systematic review and meta-analysis. ASA, LARS, LaTME, NRCTs, PRISMA, QoL, TaTME
26  2021 Comparison of patient-reported quality of life and functional outcomes following laparoscopic and transanal total mesorectal excision of rectal cancer. EORTC, LARS, TaTME
27  2021 Comparison of the short-term operative, Oncological, and Functional Outcomes between two types of robot-assisted total mesorectal excision for rectal cancer: Da Vinci versus Micro Hand S surgical robot. CCI, TME
28  2021 Connection between traumatic frontal intracerebral hemorrhage and lower urinary tract symptoms. LUTS, MRI
29  2021 Correlation between ultrasound bladder parameters with severity of symptoms and response to treatment in patients with benign prostatic hyperplasia under medical treatment. BPH, IPP
30  2021 Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia. BPH, PSAs, PUL, QALYs, WVTT
31  2021 Development and Validation of the Satisfaction Survey for Inflatable Penile Implant (SSIPI). IPP, PRO, SEAR, SSIPI
32  2021 Dietary glycine improves urine storage symptoms in urology outpatients. GSA, N-QOL, OABSS
33  2021 Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial. BPH, LUTS, MOSSS
34  2021 Early effects of different irradiation techniques used in the treatment of prostate cancer on urination BTCS, CK, HDR, LDR, LINAC, TTCS
35  2021 Effect of lateral lymph node dissection on the quality of life and genitourinary function after neoadjuvant chemoradiotherapy for rectal cancer. EORTC
36  2021 Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia. BPH/LUTS, OAB
37  2021 Effect of Transurethral Resection of the Prostate on Urodynamic Parameters in Patients with Benign Prostatic Enlargement with Upper Urinary Tract Dilatation. BPE, TURP, UDS
38  2021 Effect of vacation on urinary symptoms in health care workers: an Italian multicenter study. LUTS, NSWs, OAB-q SF, TWs, WRQOL
39  2021 Effectiveness and Safety of Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms from Benign Prostatic Hyperplasia in Men with Concurrent Localized Prostate Cancer. LUTS, PAE, PCa, QoL, RT
40  2021 Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia. BFT, BL, BPH, DV, GRR, HGB, HST, IIEF, IUT, OT, PKEP, PVR, PW, QoL, RTW, SSC, TURP
41  2021 Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A systematic review and meta-analysis. AEs, BPH, GITS
42  2021 Efficacy and tolerability of metallic stent in patients with malignant prostatic obstruction secondary to prostatic cancer. PC, QoL
43  2021 Efficacy of holmium laser enucleation in patients with a small (less than 30 mL) prostate volume. ePV, HoLEP, PVR
44  2021 Eight Days of Water-Only Fasting Promotes Favorable Changes in the Functioning of the Urogenital System of Middle-Aged Healthy Men. beta-HB, Ch-T, DHEA, FSH, LH, Pr, PSA-F, PSAt, PV, SHGB, T-F, T-T, TTV
45  2021 Endoscopic transvesical adenomectomy of the prostate, a new minimally invasive approach for large benign prostatic hyperplasia. What has our experience taught us? BPH, ETAP
46  2021 Epilobium angustifolium L. extract with high content in oenothein B on benign prostatic hyperplasia: A monocentric, randomized, double-blind, placebo-controlled clinical trial. BPH, EAEs, PSA, PV, PVR
47  2021 Evaluation of neurogenic bladder outlet obstruction mimicking sphincter bradykinesia in male patients with Parkinson's disease. PD, PVR
48  2021 Factors affecting response to 5-azacytidine and prognosis of myelodysplastic syndrome. Is long-term survival a realistic goal? HMAs, MDS
49  2021 Five-Year Results of a Prospective Multicenter Trial: AdVance XP for Postprostatectomy-Incontinence in Patients with Favorable Prognostic Factors. IQOL, PGI-I, VAS
50  2021 Functional and Patient Reported Outcomes Following Total Glans Resurfacing. IIEF, LS, PC, PROs, TGR
51  2021 GreenLight Laser™ Photovaporization versus Transurethral Resection of the Prostate: A Systematic Review and Meta-Analysis. GLL-PVP, PVR, RR, RR, RR, TURP
52  2021 Head-to-head comparison of prostatic urethral lift and water vapor thermal therapy for the treatment of symptomatic benign prostatic hyperplasia: a real-life study. BPH, QoL
53  2021 Helical tomotherapy for prostate cancer radiation therapy: An audit of early toxicity and quality of life. GI, GU, QoL, RT
54  2021 High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes. ERFE, GDF15, MDS, OS
55  2021 High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis. IIEF-5, LRFS, MFS, MHB, OS, RRFS
56  2021 Holmium laser en-bloc enucleation of the prostate: Bi-centric prospective evaluation of 109 consecutive cases. BOO, BPH, HoLEP, LUTS, OP, PVR, QoL, TURP
57  2021 Holmium laser enucleation of the prostate with Virtual Basket mode: faster and better control on bleeding. BPH, HoLEP, PVR, QOLS
58  2021 Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes. BM, MDS, OS
59  2021 Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms. AUC, ISUP, LUTS, PSA, sPCa
60  2021 Impact of COVID-19 pandemic on lower urinary tract symptoms in patients with benign prostatic hyperplasia and predictors of urine retention in such patients. BPH, COVID-19, LUTS, PVR
61  2021 Impact of detrusor underactivity on the postoperative outcomes after benign prostatic enlargement surgery. BCI, DUA, LUTS, PVP
62  2021 Improvement of quality of life and symptom burden after robot-assisted radical prostatectomy in patients with moderate to severe LUTS. LUTS, MCID, QoL, RARP
63  2021 Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study. BPH, LUTS, WTFS
64  2021 Improving Cone-Beam CT Angiography for Prostatic Artery Embolization: Is a Low-Dose Protocol Equivalent to the Standard? CT, IIEF, NTE, PAE, QoL, UCLA-PCI
65  2021 Increased serum C-reactive protein is an adverse prognostic factor in low-risk myelodysplastic syndromes. CI, CRP, HR, MDS
66  2021 Influence of the median lobe on the results at 4 years of the prostate vaporization by GreenLight laser. ML, PVP, PVR, Qmax
67  2021 Initial single centre experience of Aquablation of the prostate using the AquaBeam system with athermal haemostasis for the treatment of benign prostatic hyperplasia: 1-year outcomes. MSHQ-EjD
68  2021 Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis. PVR, TURP
69  2021 Is intravesical prostatic protrusion associated with more complications in benign prostatic hyperplasia patients? AUR, BPH, BWT, CUR, IPP, PSA, PVR, UTI
70  2021 Is there any priority between the alpha blockers on voiding functions after transrectal ultrasound guided prostate biopsy? ---
71  2021 Is there any Relationship between Total Prostate Volume, Intravesical Prostatic Protrusion and Lower Urinary Tract Symptoms in Adult Nigerian Men with Benign Prostatic Enlargement? DRE, IPP, LUTS, TPV
72  2021 Is there concordance between overactive bladder and detrusor overactivity in men with predominant storage urinary symptoms referred to Functional Urology and Urodynamics Units? 3dBD, B-SAQ, DO, LUTS, OAB, UDS, UUI
73  2021 Is there relationship between serum uric acid levels and lower urinary tract symptoms, prostate volume, and PSA in men without cancer? A prospective population-based study. BPH, UA
74  2021 Is thulium laser vapoenucleation of the prostate equally safe and effective in elderly patients? A propensity score matched analysis of early perioperative and functional outcomes. PSA, Pvol, PVR, ThuVEP
75  2021 Lower Urinary Tract Functional Assessment of Men Undergoing Radical Prostatectomy: Correlation of Preoperative Clinical and Urodynamic Parameters. LUTS, OAB, RP
76  2021 Lower urinary tract symptoms among male medical students and its relationship with khat chewing habit: A cross-sectional study. LUTS
77  2021 Lower urinary tract symptoms in rheumatoid arthritis and spondyloarthritis male patients versus controls. ED, IIEF-5, LUTS, QoL, RA, RD, SpA
78  2021 Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial. CT, GI, GU, MRI, PCa, QoL, SBRT
79  2021 Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12-month clinical outcomes of a phase I study. AEs, BPO, IQR, MRI, PSA, TULSA
80  2021 Meta-Analysis of the Efficacy and Safety of Imidafenacin for Overactive Bladder Induced by Benign Prostatic Hyperplasia in Men Receiving Alpha-Blocker Therapy. BPH, OAB
81  2021 MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up. FLA, mpMRI, PSA, QoL, SHIM
82  2021 MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. GG, IIEF-15, IQR
83  2021 Multiparametric MRI may Help to Identify Patients With Prostate Cancer in a Contemporary Cohort of Patients With Clinical Bladder Outlet Obstruction Scheduled for Holmium Laser Enucleation of the Prostate (HoLEP). BOO, DRE, HoLEP, PCa
84  2021 Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia. CENTRAL, CI, CoE, PAE, PUL, RCTs, RR, TURP
85  2021 Non-Invasive Predictors of Response to Tamsulosin for Benign Prostatic Obstruction. BPO, PVR, QoL, UFM
86  2021 One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia. BPH, LUTS
87  2021 Patient assessment of lower urinary tract symptoms using the international prostate symptom score following low-dose-rate prostate brachytherapy. AUR, LDR, US
88  2021 Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer. EBRT, EPIC-CP, GI, GU, MVA, PCa, PRO
89  2021 Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of Outcomes. HDR, LDR, MID, PRQOL, SBRT, SHIM
90  2021 Personality Traits and Urinary Symptoms Are Associated with Mental Health Distress in Patients with a Diagnosis of Prostate Cancer. TIPI
91  2021 Photoselective sharp enucleation of the prostate with a front-firing 532-nm laser: an innovative surgical technique for benign prostatic hyperplasia-a single-center study of 475 cases. PSA, PVR, QoLs
92  2021 Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia. BPH, GSTP1, LUTS, MS, PSA, PV, RV, S-BPH group
93  2021 Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center. BPH, EF, EjF, LUTSs, MSHQ-EjD-SF, PVR, UFM
94  2021 Prevalence of lower urinary tract symptoms in patients with cardiovascular disease. LUTS
95  2021 Prospective study of urinary function and analysis of risk factors after rectal cancer surgery. ASA
96  2021 Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: 2-yr Outcomes of a Randomised, Open-label, Single-centre Trial. LUTS/BPO, PAE, TURP
97  2021 Prostatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study. ANOVA, LUTS, PAE, TURP, UK-ROPE
98  2021 Prostatic artery embolization for giant prostatic hyperplasia: a single-center experience. PAE
99  2021 Prostatic Urethral Lift in Patients With Obstructive Median Lobes: A Single Surgeon Experience at an Academic Center. OML, PUL, QoL
100  2021 Pumpkin seed oil (Cucurbita pepo) versus tamsulosin for benign prostatic hyperplasia symptom relief: a single-blind randomized clinical trial. BMI, BPH, QoL